论文部分内容阅读
目的:研究新辅助化疗联合保乳术对于乳腺癌患者临床治疗的效果影响分析。方法:选取2009年1月至2015年1月期间我院收治的乳腺癌患者100例,随机分为观察组和对照组各50例,其中观察组给予新辅助化疗结合保乳术治疗的方法,对照组给予传统乳腺癌根治术治疗的方法,比较两组患者的临床疗效。结果:观察组患者在手术时间、术中出血量、并发症发生率及住院天数等数据指标均明显优于对照组(P<0.05)。结论:新辅助化疗联合保乳术在临床治疗乳腺癌方面临床疗效显著,手术时间短、术中出血量少、术后并发症少、住院时间短、患者满意度高,值得临床广泛应用。
Objective: To study the effect of neoadjuvant chemotherapy and breast-conserving surgery on the clinical effect of breast cancer patients. Methods: A total of 100 breast cancer patients admitted to our hospital from January 2009 to January 2015 were randomly divided into observation group (50 cases) and control group (50 cases). The patients in the observation group received neoadjuvant chemotherapy combined with breast-conserving therapy, The control group was given the traditional method of radical mastectomy, and the clinical efficacy of the two groups was compared. Results: Data of the observation group were significantly better than those of the control group at operation time, intraoperative blood loss, complication rate and hospitalization days (P <0.05). Conclusion: Neoadjuvant chemotherapy combined with breast conserving surgery in clinical treatment of breast cancer significant clinical efficacy, short operative time, less blood loss, fewer postoperative complications, shorter hospital stay, patients with high satisfaction, it is widely used in clinical.